- Bewertet: Format: eBook (ePUB)
Das Buch als Fortsetzung von Death Benefit ist wiederum ein gelungenes Werk. Wer etwas medizinische oder wissenschaftliche Interessen oder Kenntnisse hat wird dieses Buch ganz sicher mögen. Fesselnd.
A lavishly funded, security-conscious nanotechnology institute in the foothills of the Rockies, Nano is ahead of the curve in the competitive world of molecular manufacturing, including the construction of microbivores, tiny nanorobots with the ability to gobble up viruses and bacteria.
But when Pia Grazdani takes a job there, she's shocked by the secretive corporate culture. She's warned by her boss not to investigate the other work being done at the gigantic facility, nor to ask questions about the source of the seemingly endless capital that funds the institute's research. And when Pia encounters a fellow employee on a corporate jogging path suffering the effects of a seizure, she soon realizes she may have literally stumbled upon Nano's human guinea pigs. Is the tech giant on the cusp of one of the biggest medical discoveries of the twenty-first century—a treatment option for millions—or have they already sold out to the highest bidder?
Dr. Robin Cook is the author of thirty-one previous books and is credited with popularizing the medical thriller with his wildly successful first novel, Coma. He divides his time between New Hampshire and Florida. His most recent bestsellers are Death Benefit, Cure, and Intervention.